LuanP. V. (2023) “Blood group B can be a predictor of the EGFR mutations in patients with lung adenocarcinoma”, Journal of 108 - Clinical Medicine and Phamarcy, 19(ta). doi: 10.52389/ydls.v19ita.2509.